Nourish Raises $100M to Revolutionize Chronic Disease Care with AI

NEW YORK, NY – May 19, 2026 – Nourish, a virtual metabolic health clinic, today announced a $100 million Series C funding round, catapulting its total capital raised to $215 million. The investment underscores a significant bet on the company’s model, which combines a massive network of dietitians with proprietary AI to combat America's chronic disease epidemic.

The round was led by Menlo Ventures, a firm with a keen eye for technology disrupting the healthcare space. The impressive roster of participants includes Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, and Maverick Ventures, among others. The capital infusion is earmarked to scale Nourish’s clinical network, accelerate its AI development, and deepen its foundational partnerships with health plans and hospital systems across the country.

“Chronic disease is the largest cost driver in U.S. healthcare, and the system still isn't built to treat it,” said Aidan Dewar, Co-Founder and CEO of Nourish. “Too often, patients get expensive, reactive, fragmented care that doesn't actually make them healthier. We've built the care model and technology to change that.”

An AI-Native Approach to a National Crisis

At the heart of Nourish's strategy is its AI-native platform, designed to tackle a crisis affecting nearly 200 million Americans living with nutrition-related chronic conditions. These diseases are the primary drivers of the nation's nearly $5 trillion annual healthcare expenditure. Nourish’s approach is twofold, deploying AI agents to support both patients and its vast network of clinicians.

For patients, an AI health agent integrated into the company’s mobile app serves as a constant companion. With hundreds of thousands of monthly active users, the tool provides proactive support for behavior change and helps coordinate care between appointments, effectively acting as a 24/7 coach. This continuous engagement is critical for fostering the long-term lifestyle adjustments necessary to manage chronic illness.

For its more than 10,000 Registered Dietitians, AI copilot agents automate time-consuming administrative work. These tools can generate session notes, streamline complex prior authorization workflows for medications, and surface critical clinical insights from patient-reported data. By offloading these tasks, the platform allows dietitians to operate at the top of their license, focusing their expertise on direct patient care and complex decision-making.

This tech-forward approach aligns perfectly with the investment theses of its prominent backers. Menlo Ventures, whose partner J.P. Sanday will join the Nourish board, has focused on finding companies that achieve a “healthcare trinity” of increased access, better outcomes, and lower costs. Similarly, Index Ventures has identified AI adoption as a key force reshaping the industry, particularly in high-trust domains like healthcare.

Bending the Cost Curve with Clinical Results

While the technology is a key enabler, the company's leadership emphasizes that its core is a human-led care model that delivers tangible results. Every patient is paired with a Registered Dietitian for virtual sessions, receiving a personalized care plan that is covered by insurance for over 200 million Americans.

The clinical outcomes reported are a significant factor in its success with payers. Nourish cites an average of 8% weight loss, a 1.3-point reduction in A1C for diabetic patients, a 31-point drop in LDL cholesterol, and a 23-point reduction in systolic blood pressure. These improvements translate directly into financial savings, with the company claiming it saves health plans over $2,000 per patient annually.

This ability to deliver measurable ROI is what attracts investors and partners alike. “Chronic disease is the central failure of U.S. healthcare — nearly 200 million Americans affected, trillions spent, and outcomes that still don't move,” said J.P. Sanday, Partner at Menlo Ventures. “What Nourish has built in four years is remarkable: a care model that actually bends the cost curve, with 10,000 dietitians, deep payer relationships, and clinical outcomes patients stick with. Most companies get one of those things right. Nourish has all of them.”

Navigating the GLP-1 Revolution Responsibly

The recent explosion in GLP-1 medications like Ozempic and Wegovy has created a seismic shift in metabolic health, but it has also introduced new challenges. While highly effective, the drugs are expensive, and studies show that fewer than half of patients remain on them after six months, with most regaining the weight they lost without sustained lifestyle support.

Nourish is positioning itself as a solution to this problem. The company integrates responsible prescribing of brand-name, insurance-covered GLP-1s into its nutrition-first care model. This strategy ensures that medication is not a standalone treatment but part of a comprehensive, dietitian-led program designed for long-term behavior change and sustainable health outcomes. For eligible patients, the model layers in medical care, including lab testing and medication management, coordinated with their existing providers.

This integrated approach addresses a critical need for payers, who are under immense pressure to manage the high cost of GLP-1s while ensuring patients achieve lasting results. By combining medication with the proven efficacy of nutrition counseling and behavior change support, Nourish offers a more durable and cost-effective solution than medication alone.

Scaling Access Through Strategic Partnerships

Founded just four years ago, Nourish has achieved remarkable scale, having completed millions of appointments and more than tripling its growth year-over-year. This rapid expansion has been fueled by a robust ecosystem of partnerships that form the bedrock of its business model.

The company has secured contracts with hundreds of the nation’s leading health plans, making its services available to over 200 million people across all 50 states, typically at no out-of-pocket cost to the patient. This eliminates one of the most significant historical barriers to accessing nutrition care.

Beyond payers, Nourish has cultivated a powerful referral engine. Tens of thousands of providers from over 250 health systems actively refer hundreds of thousands of patients to its platform. This deep integration into the existing healthcare infrastructure validates its clinical model and provides a steady stream of patients who can benefit from its services. With the new funding, Nourish plans to deepen these relationships, further embedding its AI-powered, dietitian-led care model as a new standard for treating and reversing chronic disease in America.